Jun 12 |
Biogen Inc. (BIIB) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 12 |
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
|
Jun 11 |
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
|
Jun 11 |
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
|
Jun 11 |
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
|
Jun 11 |
Donanemab approval would fuel growth of amyloid-blocking Alzheimer’s drugs, analysts say
|
Jun 11 |
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
|
Jun 10 |
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
|
Jun 10 |
Biogen, Eisai get January 2025 FDA action date for monthly Leqembi
|
Jun 10 |
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
|